½ÃÀ庸°í¼­
»óǰÄÚµå
1612305

¼¼°èÀÇ ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå : Á¦Ç°, ÀûÀÀÁõ, À¯Åë ä³Î, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Automatic Pill Dispenser Market by Product (Centralized Automatic Dispenser, Decentralized Automatic Dispenser), Indication (Neurodegenerative Disorders & Dementia, Physical Disability), Distribution Channel, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 33¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 36¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 7.94%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 57¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀº º¹¿ë ¾îµåÈ÷¾î·±½º¸¦ Çâ»ó½Ã۰í, ƯÈ÷ ¸¸¼º ÁúȯÀÌ ÀÖ´Â »ç¶÷°ú ³ëÀÎ, ÀÎÁö Àå¾Ö°¡ ÀÖ´Â »ç¶÷ÀÇ ÀÏ»óÀûÀÎ º¹¾à ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϵµ·Ï ¼³°èµÈ ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀåÄ¡´Â °Ç°­ °ü¸® ȯ°æ, ÀçÅà °£È£ ¹× º¹Áö ½Ã¼³¿¡¼­ ÇʼöÀûÀ̸ç Åõ¾à ½Ç¼ö¸¦ ¹æÁöÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ Á¤½Ã ¹× Á¤È®ÇÑ Á¦ÇüÀ» º¸ÀåÇÕ´Ï´Ù. °í·ÉÈ­ Àα¸ Áõ°¡, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀçÅà °Ç°­ °ü¸® ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. AI¿Í °°Àº ½º¸¶Æ® ±â¼úÀÌ ÅëÇÕµÇ¾î »ç¿ëÀÚ °æÇè°ú È¿À²¼ºÀÌ Çâ»óµÇ°í ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ó¹æ °ü¸®, ȯÀÚ ¿¬°á ±â¼ú Çõ½Å¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº »ç¿ëÀÚ Ä£È­ÀûÀÌ°í ¾ÈÀüÇϰí ÀûÀÀ·ÂÀÌ ³ôÀº Á¦Ç°À» °³¹ßÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÷´Ü Á¦Á¦ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ³·Àº ÀÎÁöµµ, µ¥ÀÌÅÍ ¾ÈÀü¼º ¹× °³ÀÎ Á¤º¸ º¸È£ ¹®Á¦¿Í °°Àº ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¼ö¸® ¹× ÀåºñÀÇ ½Å·Ú¼º È®º¸°¡ À庮ÀÌ µÉ °¡´É¼ºµµ ÀÖ½À´Ï´Ù. ÀÇ¾à µ¿Çâ ¿¹Ãø ¹× º¹¾à ¾ÈÀü ±â´É °­È­¸¦ À§ÇÑ AI ÁÖµµÇü ¾Ö³Î¸®Æ½½º Á¶»ç´Â ÀÌ ½ÃÀåÀÇ Ãß°¡ ÁøÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Áö¼ÓÀûÀÎ R&D¿Í Àü·«Àû ÆÄÆ®³Ê½ÊÀÇ Çʿ伺À» °­Á¶Çϰí, Á¦Ç° ¶óÀξ÷À» È®´ëÇϸç, º¸´Ù Æø³ÐÀº ¼ÒºñÀÚÃþÀ» ĸóÇÕ´Ï´Ù.,ÀÌ ±â°è ÀåºñÀÇ ºñ¿ë È¿À²¼º°ú °Ç°­»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎÁöµµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù. ±×¸®°í ±× ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 33¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 36¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 57¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 7.94%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ÁúȯÀ̳ª À¯Àü¼º ÁúȯÀÇ ¼¼°è Áõ°¡
    • ¼öÀÛ¾÷¿¡ ÀÇÇÑ Åõ¾àÀ̳ª ¾àÁ¦ Ä«¿îÆ®ÀÇ ½ÇŸ¦ ÃÖ¼ÒÇÑÀ¸·Î ¾ïÁ¦ÇÏ´Â ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ÀÇ Á¦Ç° ȸ¼ö ¹ß»ý
  • ½ÃÀå ±âȸ
    • Á¤Á¦ ºÐÁÖ¸¦ À§ÇÑ °í±Þ AI, IoT, ·Îº¿ ±â¼ú µµÀÔ
    • ÇコÄɾÀÇ ¾×¼¼½º¸¦ ÃËÁøÇØ, ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ ´ëó
  • ½ÃÀåÀÇ °úÁ¦
    • °ú´ÙÅõ¿©¿Í °ú¼ÒÅõ¿© Á¶°ÇÀ» °í·ÁÇÏ´Â µð¹ÙÀ̽ºÀÇ ¹«·ÂÇÔ°ú ±â¼úÀû Á¦¾à

Porter's Five Force : ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Î ¿¹»óÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±â À§ÇÑ ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϰí, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ¸¸¼º ÁúȯÀ̳ª À¯Àü¼º ÁúȯÀÇ ¹ß»ý·üÀÌ »ó½Â
      • ¼öÀÛ¾÷¿¡ ÀÇÇÑ Åõ¾àÀ̳ª ¾àÁ¦ Ä«¿îÆ®ÀÇ ½Ç¼ö¸¦ ÃÖ¼ÒÇÑÀ¸·Î ¾ïÁ¦ÇÏ´Â ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ÀÚµ¿ ¾àÁ¦ ºÐ¹è±âÀÇ Á¦Ç° ¸®ÄÝ ¹ß»ý °Ç¼ö
    • ±âȸ
      • °í±Þ AI, IoT, ·Îº¿ ±â¼úÀ» Á¤Á¦ ºÐ¹è¿¡ ÅëÇÕ
      • ÇコÄɾÀÇ ¾×¼¼½º¸¦ ÃËÁøÇØ, ÀÚµ¿ ¾àÁ¦ ºÐ¹è±âÀÇ µµÀÔÀ» ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó
    • °úÁ¦
      • °ú´ÙÅõ¿©³ª °ú¼ÒÅõ¿© »óȲÀ̳ª ±â¼úÀû Á¦¾àÀ» °í·ÁÇÒ ¼ö ¾ø´Â µð¹ÙÀ̽º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç°: ºÐ»êÇü ÀÚµ¿ Åõ¾à ÀåÄ¡ÀÇ µµÀÔÀ¸·Î À̾îÁö´Â Á¤Á¦ Åõ¾àÀÇ ¿ø°Ý °¨½ÃÀÇ Çʿ伺
    • ÀûÀÀÁõ: °í·ÉÈ­ »çȸ¿¡¼­ÀÇ ½Å°æÅðÇ༺ Áúȯ ¹× Ä¡¸ÅÀÇ ¹ß»ý·üÀÇ »ó½Â
    • À¯Åë ä³Î: ȯÀÚÀÇ Æí¸®¼ºÀÌ ³ôÀº ±¸¸Å ¿É¼ÇÀÇ ÃëÇâ¿¡ µû¶ó ÀüÀÚ»ó°Å·¡¿Í ¿Â¶óÀÎ À¯Åë ä³ÎÀÌ È®´ë
    • ÃÖÁ¾»ç¿ëÀÚ : ¿ø°Ý ÀÇ·á½Ã¼³ÀÇ È®´ë¸¦ À§ÇÑ ´ëó¿¡ ÀÇÇØ ÀçÅÃÄ¡·á±â±âÀÇ Áøº¸°¡ ÃËÁøµÈ´Ù
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå : Á¦Ç°º°

  • ÁýÁß ÀÚµ¿ µð½ºÆæ¼­
  • ºÐ»êÇü ÀÚµ¿ µð½ºÆæ¼­
    • ÀÚµ¿ ´ÜÀ§ ¿ë·® ºÐ¹è ½Ã½ºÅÛ
    • ¾à±¹ ±â¹Ý ÀÚµ¿ Á¦Á¦ ½Ã½ºÅÛ
    • º´µ¿ ±â¹ÝÀÇ ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛ

Á¦7Àå ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå : ÀûÀÀÁõº°

  • ½Å°æÅðÇ༺ Áúȯ°ú Ä¡¸Å
  • ½ÅüÀå¾Ö

Á¦8Àå ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦9Àå ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ȨÄɾî
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚµ¿ Á¤Á¦ µð½ºÆæ¼­ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • NMIMS STME IndoreÀÇ ÇлýÀÌ ÇコÄÉ¾î ¹× ÀÇ·á °ü¸®ÀÇ ÃÖ½ÅÀÇ Çõ½ÅÀ» °³¹ß
    • iA°¡ Euclid¿Í Á¦ÈÞÇØ ÁýÁßÇü Ç®ÇÊ¸ÕÆ® ¼Ö·ç¼ÇÀ» È®´ë
    • CVS Pharmacy°¡ QuickServe ºñŸ¹Î Á¦Á¦ ½Ã½ºÅÛÀ» µµÀÔ
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Accu-Chart
  • AceAge Inc.
  • ARxIUM Inc.
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Capsa Solution, LLC
  • Cerner Corporation by Oracle Corporation
  • CVS Health
  • FOM Industries
  • Hero Health, Inc.
  • InstyMeds Corporation
  • Koninklijke Philips NV
  • LiveFine, Inc.
  • McKesson Corporation
  • Medminder Systems, Inc.
  • MedReady
  • MOBI Technologies
  • Omnicell
  • PharmAdva, LLC
  • PharmaZell GmbH
  • Pivotell
  • Reizen, Inc.
  • ScriptPro LLC
  • Swisslog Holdings AG
  • Tabtime Limited
  • TabTimer Pty Ltd
JHS 24.12.24

The Automatic Pill Dispenser Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.62 billion in 2024, and is projected to grow at a CAGR of 7.94%, to USD 5.72 billion by 2030.

The scope of the automatic pill dispenser market encompasses solutions designed to enhance medication adherence and streamline the process of taking routine medication, particularly for individuals with chronic conditions, the elderly, and those with cognitive impairments. These devices are integral in healthcare settings, home care, and assisted living facilities, ensuring timely and accurate medication dispensing, which is crucial in preventing dosage errors and improving patient outcomes. The growing aging population, increasing prevalence of chronic diseases, and the shift towards home-based healthcare solutions are major factors propelling market growth. Additionally, the integration of smart technologies such as IoT and AI in pill dispensers enhances user experience and efficiency, presenting lucrative opportunities for innovation in real-time monitoring, prescription management, and patient connectivity. Companies can capitalize on these opportunities by developing user-friendly, secure, and highly adaptable products. However, the market faces challenges, such as high initial costs, limited awareness about advanced dispensing solutions, and concerns regarding data security and privacy. Moreover, adherence to stringent regulatory standards and ensuring device reliability can act as barriers. Innovation avenues include enhancing device personalization, expanding connectivity features, and improving the integration of these devices with broader health management systems. Research into AI-driven analytics for predicting medication adherence trends and enhancing medication safety features could drive further advancements in this market. The competitive nature of the market emphasizes the need for continuous R&D and strategic partnerships to expand offerings and capture a wider consumer base. Companies should focus on raising awareness about the cost-effectiveness and health benefits of these devices through educational initiatives and targeted marketing campaigns. By addressing these challenges and leveraging technological advancements, market players can significantly contribute to and benefit from the growing demand for automatic pill dispensers.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.62 billion
Forecast Year [2030] USD 5.72 billion
CAGR (%) 7.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automatic Pill Dispenser Market

The Automatic Pill Dispenser Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of chronic diseases and genetic disorders across the world
    • Increasing demand for minimizing manual medication and drug count blunder
  • Market Restraints
    • Incidences of product recalls of automatic pill dispensers
  • Market Opportunities
    • Incorporation of advanced AI, IoT, and robotics technologies for pill dispensing
    • Government initiatives to promote access to healthcare and propel the adoption of automatic pill dispensers
  • Market Challenges
    • Inability of the devices to account for overdosing and underdosing conditions and technical constraints

Porter's Five Forces: A Strategic Tool for Navigating the Automatic Pill Dispenser Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automatic Pill Dispenser Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automatic Pill Dispenser Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automatic Pill Dispenser Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automatic Pill Dispenser Market

A detailed market share analysis in the Automatic Pill Dispenser Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automatic Pill Dispenser Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automatic Pill Dispenser Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automatic Pill Dispenser Market

A strategic analysis of the Automatic Pill Dispenser Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automatic Pill Dispenser Market, highlighting leading vendors and their innovative profiles. These include Accu-Chart, AceAge Inc., ARxIUM Inc., Baxter International Inc., Becton, Dickinson, and Company, Capsa Solution, LLC, Cerner Corporation by Oracle Corporation, CVS Health, FOM Industries, Hero Health, Inc., InstyMeds Corporation, Koninklijke Philips N.V., LiveFine, Inc., McKesson Corporation, Medminder Systems, Inc., MedReady, MOBI Technologies, Omnicell, PharmAdva, LLC, PharmaZell GmbH, Pivotell, Reizen, Inc., ScriptPro LLC, Swisslog Holdings AG, Tabtime Limited, and TabTimer Pty Ltd.

Market Segmentation & Coverage

This research report categorizes the Automatic Pill Dispenser Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Centralized Automatic Dispenser and Decentralized Automatic Dispenser. The Decentralized Automatic Dispenser is further studied across Automatic Unit Dose Dispensing System, Pharmacy-Based Automated Dispensing System, and Ward-Based Automated Dispensing System.
  • Based on Indication, market is studied across Neurodegenerative Disorders & Dementia and Physical Disability.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Homecare and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and genetic disorders across the world
      • 5.1.1.2. Increasing demand for minimizing manual medication and drug count blunder
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recalls of automatic pill dispensers
    • 5.1.3. Opportunities
      • 5.1.3.1. Incorporation of advanced AI, IoT, and robotics technologies for pill dispensing
      • 5.1.3.2. Government initiatives to promote access to healthcare and propel the adoption of automatic pill dispensers
    • 5.1.4. Challenges
      • 5.1.4.1. Inability of the devices to account for overdosing and underdosing conditions and technical constraints
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Need for remote monitoring of pill dispensing leading to the adoption of decentralized automatic dispenser
    • 5.2.2. Indication: Rising incidences of neurodegenerative disorders & dementia in an aging population
    • 5.2.3. Distribution channel: Expansion of e-commerce and online distribution channels due to patient preference for convenient purchasing options
    • 5.2.4. End user: Advancements in homecare medical devices fuelled by initiatives to expand remote healthcare facilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Automatic Pill Dispenser Market, by Product

  • 6.1. Introduction
  • 6.2. Centralized Automatic Dispenser
  • 6.3. Decentralized Automatic Dispenser
    • 6.3.1. Automatic Unit Dose Dispensing System
    • 6.3.2. Pharmacy-Based Automated Dispensing System
    • 6.3.3. Ward-Based Automated Dispensing System

7. Automatic Pill Dispenser Market, by Indication

  • 7.1. Introduction
  • 7.2. Neurodegenerative Disorders & Dementia
  • 7.3. Physical Disability

8. Automatic Pill Dispenser Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Automatic Pill Dispenser Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospitals & Clinics

10. Americas Automatic Pill Dispenser Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Automatic Pill Dispenser Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Automatic Pill Dispenser Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. NMIMS STME Indore Students Develop Latest Innovation in Healthcare and Medicine Management
    • 13.3.2. iA Partners with Euclid to Expand Centralised Fulfillment Solutions
    • 13.3.3. CVS Pharmacy Launches QuickServe Vitamin Dispensing System
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accu-Chart
  • 2. AceAge Inc.
  • 3. ARxIUM Inc.
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson, and Company
  • 6. Capsa Solution, LLC
  • 7. Cerner Corporation by Oracle Corporation
  • 8. CVS Health
  • 9. FOM Industries
  • 10. Hero Health, Inc.
  • 11. InstyMeds Corporation
  • 12. Koninklijke Philips N.V.
  • 13. LiveFine, Inc.
  • 14. McKesson Corporation
  • 15. Medminder Systems, Inc.
  • 16. MedReady
  • 17. MOBI Technologies
  • 18. Omnicell
  • 19. PharmAdva, LLC
  • 20. PharmaZell GmbH
  • 21. Pivotell
  • 22. Reizen, Inc.
  • 23. ScriptPro LLC
  • 24. Swisslog Holdings AG
  • 25. Tabtime Limited
  • 26. TabTimer Pty Ltd
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦